🔎 Trials Near Me

Gara Jalqabaatti › Dukkana Dhiigaa › Connecticut › New Haven

Qorannoo klinikaalii Dukkana Dhiigaa New Haven, CT keessatti

Qorannoo 7 Dukkana Dhiigaa f New Haven fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Namoota walitti qabaa jiraSadarkaa 1
  • Smilow Cancer Center/Yale-New Haven Hospital, New Haven
  • Yale University, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT03816345

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · Miili 3 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT04242095

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Namoota walitti qabaa jiraSadarkaa 3
  • Yale University School of Medicine, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Smilow Cancer Hospital at Yale New Haven, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT06001788

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

Namoota walitti qabaa jiraSadarkaa 1
  • Yale University Medical Center, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT06823167

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Yale New Haven Hospital, New Haven
Umuriin hundi · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT01351545

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Namoota walitti qabaa jiraSadarkaa 1
  • Yale Cancer Center and Smilow Cancer Hospital, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT05735184

Qorannoo Dukkana Dhiigaa magaalota biroo keessatti

Qorannoo biroo New Haven keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.